Literature DB >> 8665565

Vinorelbine: an overview.

S A Johnson1, P Harper, G N Hortobagyi, P Pouillart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8665565     DOI： 10.1016/s0305-7372(96)90032-8

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  15 in total

1.  Cost utility in second-line metastatic breast cancer.

Authors:  G Berdeaux; P Hurteloup
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

2.  Pharmacokinetics, tissue distribution and excretion of vinflunine.

Authors:  Xiao-Ping Zhao; Xiao-Quan Liu; Yong-Sheng Wang; Huan Wang; Guang-Ji Wang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Apr-Jun       Impact factor: 2.441

3.  Phase I/II study of gemcitabine plus vinorelbine in non-small cell lung cancer.

Authors:  Emilio Esteban; Joaquin Fra; Norberto Corral; Miguel Valle; Juan Carrasco; Marian Sala; Javier Puerta; Enrique Estrada; Isabel Palacio; Jose Maria Vieitez; Jose Maria Buesa; Angel Jimenez Lacave
Journal:  Invest New Drugs       Date:  2002-02       Impact factor: 3.850

Review 4.  Vinorelbine: a review of its use in elderly patients with advanced non-small cell lung cancer.

Authors:  Monique P Curran; Greg L Plosker
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

5.  Quick, non-invasive and quantitative assessment of small fiber neuropathy in patients receiving chemotherapy.

Authors:  Mehdi Saad; Dimitri Psimaras; Camille Tafani; Magali Sallansonnet-Froment; Jean-Henri Calvet; Alice Vilier; Jean-Marie Tigaud; Flavie Bompaire; Marie Lebouteux; Thierry de Greslan; Bernard Ceccaldi; Jean-Michel Poirier; François-Régis Ferrand; Sylvestre Le Moulec; Olivier Huillard; François Goldwasser; Hervé Taillia; Thierry Maisonobe; Damien Ricard
Journal:  J Neurooncol       Date:  2016-01-09       Impact factor: 4.130

Review 6.  Premenopausal breast cancer: chemotherapy and endocrine therapy.

Authors:  Herbert G Sayer; Roland Kath; Kay-Oliver Kliche; Klaus Höffken
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  A new lipid-based nano formulation of vinorelbine.

Authors:  Fatemeh Bahadori; Gülaçtı Topçu; Mehmet S Eroğlu; Hayat Onyüksel
Journal:  AAPS PharmSciTech       Date:  2014-05-29       Impact factor: 3.246

8.  Capecitabine and vinorelbine in patients with metastatic breast cancer previously treated with anthracycline and taxane.

Authors:  Jin-Hee Ahn; Sung-Bae Kim; Tae-Won Kim; Sei-Hyun Ahn; Sun-Mi Kim; Jeong-Mi Park; Jung-Shin Lee; Yoon-Koo Kang; Woo Kun Kim
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

9.  VEGF neutralizing antibody increases the therapeutic efficacy of vinorelbine for renal cell carcinoma.

Authors:  Sutapa Sinha; Ying Cao; Shamit Dutta; Enfeng Wang; Debabrata Mukhopadhyay
Journal:  J Cell Mol Med       Date:  2008-11-07       Impact factor: 5.310

10.  Vinflunine in the treatment of bladder cancer.

Authors:  Mark Bachner; Maria De Santis
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.